Skip to content
HeyJared

This is Cruxx

This is Cruxx is a podcast network for founders, CEOs, investors, and operators building the next generation of MedTech.

YouTube · GB · Official site

Indexed videos, last 90 days
48
Latest publication
Sep 18, 2026
Audience
~160 subscribers
Earliest in this view
Jul 8, 2026

Latest videos

  1. Video · Sep 18, 2026

    The Tinnitus Reality Most Investors Don't Understand (opens the original)

    Excerpt · 1 min · 1,145 views by Sep 30, 2026

    Read excerpt

    🔊 "It's just some ringing in the ears." That's what Dr. Vachicouras used to think too, until he met patients whose tinnitus was so severe it cost them their sleep, their social lives, and their friendships. He breaks down why this condition is so easy to underestimate: it ranges from mild annoyance to genuinely debilitating, and most people, including investors, only ever picture the mild end. ENTs who treat these patients daily know the real scale of the problem. Everyone else is catching up. T

  2. Video · Sep 17, 2026

    Why Your Brain Is Basically Tofu (And Why That Matters for Neurotech) (opens the original)

    Excerpt · Positive tone · 1 min · 272 views by Sep 30, 2026

    Read excerpt

    🍮 Panna cotta. Tofu. That's how Dr. Vachicouras describes the brain, spinal cord, and peripheral nerves, and it's the mechanical insight that changed everything about his approach to neural interfaces. Unlike rigid implants that fight against tissue that's constantly moving with blood flow, breathing, and CSF, his team engineered stretchable soft electronics that match the mechanical properties of the tissue itself. The result is a fundamentally different safety profile than what you see from ri

  3. Video · Sep 16, 2026

    From Nanotech to Neurotech: Why This Founder Bet on the Brain (opens the original)

    Excerpt · Neutral tone · 1 min · 107 views by Sep 30, 2026

    Read excerpt

    🧠 What happens when a microelectronics engineer decides the brain is the next frontier? Dr. Vachicouras explains how soft, foldable electrodes are rewriting the rules of brain interfaces, offering the same coverage as rigid implants but with far less invasiveness. He also breaks down a stark divide in how investors think: US backers bet on vision and team, European investors want market proof, regulatory clarity, and a real go-to-market plan before they write a check. This is a founder who sees

  4. Video · Sep 16, 2026

    Your Brain Is the Softest Thing in Your Body, that's Why All Implants Are Wrong with Dr. Vachicouras (opens the original)

    Excerpt · Neutral tone · 56 min · 44 views by Sep 30, 2026

    Read excerpt

    In this episode of the Crux of Neuro, Liz Moyles sits down with Dr. Nicolas Vachicouras, PhD, CEO and Co-Founder of Neurosoft Bioelectronics, a Geneva and New York-based neurotechnology company spun out of EPFL, developing the world's softest, stretchable brain interfaces. Nicolas takes us through his journey from studying the bionic eye, to building brain interfaces for epilepsy, tetraplegics, and severe tinnitus and why the key to all of it starts with matching the mechanical properties of the

  5. Video · Sep 4, 2026

    The $800 Billion Healthcare Cost Nobody Talks About (opens the original)

    Excerpt · 1 min · 22 views by Sep 30, 2026

    Read excerpt

    💸 Dr. Leo Petrossian breaks down the real math behind US healthcare spending. Cardiovascular care gets the headlines at $1.1 trillion, but neurological disease is a massive, underestimated line item that most people wildly guess too low. He points to a 2017 study by Dr. Gooch that pegged the cost at $800 billion, a number that's only climbing since. If you think neuro conditions are a niche problem, this will change your mind. Follow for more raw conversations with the builders reshaping healtht

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

~160 subscribers

Measured Sep 19, 2026

Source's subscribers, not the number who saw an individual piece.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about This is Cruxx